$25.68
+0.18 (+0.71%)
Performance
1D
—
1W
—
1M
—
3M
+21.53%
6M
+31.96%
1Y
+210.14%
YTD
+10.26%
Open$25.65
Previous Close$25.50
Day High$26.00
Day Low$25.00
52W High$28.72
52W Low$7.06
Volume—
Avg Volume1.17M
Market Cap3.19B
P/E Ratio—
EPS$-3.30
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$22.13
Above
SMA 200
$15.14
Above
RSI (14)
36.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
18 analysts
Price Target
+291.4% upside
Current
$25.68
$25.68
Target
$100.50
$100.50
$77.00
$100.50 avg
$121.27
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 285.65M | 219.46M | 841.86M |
| Net Income | -408,239,937 | -282,280,226 | -67,570,170 |
| Profit Margin | -142.9% | -135.8% | -8.0% |
| EBITDA | -434,832,420 | -317,371,541 | -58,220,570 |
| Free Cash Flow | — | — | -41,442,789 |
| Rev Growth | +30.2% | +30.2% | +8.2% |
| Debt/Equity | 0.16 | 0.16 | 0.24 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |